250 Mg RELIEVEN PLUS SYRUP - Ibuprofen (100mg) + Paracetamol (162.5mg) SAFEGRA SUSPENSION -Fexofenadine (30mg/5ml) SUHANI SUBAH SYRUP -Cassia Angustifolia 350 Mg , Tamarindus Indica 300 Mg , Cassia Fistula 350 Mg SILYTOIN PLUS SYRUP - Silymarin 35 Mg , Thiamine Hydrochloride 1.4 Mg SILYTOIN SYRUP - Silymarin (35mg/5ml) SOCRAMAC O SYP - Sucralfate (1000mg/10ml) + Oxetacaine (20mg/10ml) VITSAFE-5G SYRUP - Lycopene10% 1000 Mcg, Lutin 6% 1mg,biotin10% 30 Mcg,grean Tea Extarct 2,5 Mg, Grape Seed Extact 1.2 Mg, Ginko Biloba 1.2 Mg, Garlic Extrcat 0.5 Mg,ginger Extract 0.5mg,citrus Bioflavnoid 1mg, Vitamin C 10 Mg (each 10 Ml Contain) ZINOTAL SYRUP - ZINC GLUCONATE (20MG/5ML) ALCOVIT C SYRUP - Ferric Ammonium Citrate 160mg Eq
Key takeaways Regulatory Status: As of April 2026, BPC-157 is classified as a Category 2 bulk drug substance by the FDA prohibited in compounding under Section 503A and 503B
Regular screening, balanced nutrition, and expert medical guidance are key to effective pcos management
FDAs introductory briefing document states that the agency does not intend to issue a final determination until it has considered input from the advisory committee process and finalized its reviews
